Research graph
References from Cardiovascular-kidney-metabolic (CKM) syndrome stages, cardiometabolic risk-factor clustering, and QTc prolongation in a rural western Chinese population: a cross-sectional study. Local targets link to admitted publications; unresolved targets remain external evidence.
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
10.1161/cir.0000000000001184 · 2023 · External reference
Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study
10.1016/j.jacasi.2025.04.007 · 2025 · External reference
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA)
10.1161/circulationaha.104.515072 · 2005 · External reference
Ethnic disparities in prevalence and clustering of cardiovascular disease risk factors in rural Southwest China
10.1186/s12872-019-1185-1 · 2019 · External reference
Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China
10.1136/bmjopen-2017-020530 · 2018 · External reference
Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
10.1093/eurjpc/zwaf708 · 2025 · External reference
Epidemiology of cardiovascular-kidney-metabolic syndrome
10.1038/s41581-026-01078-w · 2026 · External reference
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
10.1016/s0140-6736(19)32008-2 · 2020 · External reference
Gender-specific associations between metabolic syndrome components and electrocardiographic abnormalities: evidence from the Birjand University of Medical Sciences Employee Health Study (BUMS EHCS)
10.1038/s41598-026-62213-y · 2026 · External reference
The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: a cross-sectional study
10.1111/jch.14867 · 2024 · External reference
Left ventricular hypertrophy in hypertension: is the electrocardiogram enough for risk stratification?
10.1111/jch.14614 · 2023 · External reference
Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment
10.1016/j.nefroe.2024.11.011 · 2024 · External reference
Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management
10.1152/ajpcell.00499.2025 · 2026 · External reference
Cumulative incidence of mortality associated with cardiovascular-kidney-metabolic (CKM) syndrome
10.1681/asn.0000000637 · 2025 · External reference
Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: a prospective cohort study
10.1016/j.ajpc.2025.100985 · 2025 · External reference
Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
10.1186/s12933-025-02735-3 · 2025 · External reference
Prevalence of cardiovascular-kidney-metabolic syndrome in areas of Southern China where ethnic minority populations reside: a cross-sectional study
10.3389/fendo.2026.1818782 · 2026 · External reference
Sex differences in the progression of cardiovascular-kidney-metabolic syndrome
10.1093/ehjopen/oeaf162 · 2025 · External reference
Predictive value of QT interval correction formulas for all-cause mortality in patients with left bundle branch block
10.1186/s12872-026-05661-8 · 2026 · External reference
QT interval prolongation and mortality in sepsis: a retrospective cohort study from the MIMIC-IV database
10.1186/s12872-026-05519-z · 2026 · External reference
Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography
10.1111/jch.13991 · 2020 · External reference
Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: insight from the Korean Hypertension Cohort Study
10.1111/jch.14583 · 2022 · External reference
The burden of cardiovascular disease in China: incidence estimates from national surveillance (2023)
10.1016/j.jacc.2025.08.060 · 2026 · External reference
Prevalence, component patterns, and lifestyle correlates of metabolic syndrome among civil servants undergoing routine health examinations in Guangzhou, China: a cross-sectional study
10.3389/fpubh.2026.1893244 · 2026 · External reference
Rural, urban and suburban differences in the prevalence of metabolic syndrome in individuals aged ≥ 50 years in Northwest China
10.3389/fpubh.2025.1589196 · 2025 · External reference
Unresolved reference
2024 · External reference
Validation of the A&D BP UA-651 device for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010
10.1097/mbp.0000000000000020 · 2014 · External reference
Validation of the A&D BP UA-651 device with a wide-range cuff for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010
10.1097/mbp.0000000000000100 · 2015 · External reference
Validation of the A&D UA-651 Plus/UA-651SL Plus automated sphygmomanometer according to the ISO 81060-2, 2018 and ISO 81060-2 Amendment 1, 2020, which resulted in the currently pending Amendment to Amendment 1
10.1111/jch.14464 · 2022 · External reference
Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: a prospective cohort study
10.1016/j.ajpc.2025.100985 · ExternalCitation · doi-reference
Prevalence and Mortality of Cardiovascular-Kidney-Metabolic Syndrome in China: A Nationwide Population-Based Study
10.1016/j.jacasi.2025.04.007 · ExternalCitation · doi-reference
The burden of cardiovascular disease in China: incidence estimates from national surveillance (2023)
10.1016/j.jacc.2025.08.060 · ExternalCitation · doi-reference
Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment
10.1016/j.nefroe.2024.11.011 · ExternalCitation · doi-reference
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
10.1016/s0140-6736(19)32008-2 · ExternalCitation · doi-reference
Epidemiology of cardiovascular-kidney-metabolic syndrome
10.1038/s41581-026-01078-w · ExternalCitation · doi-reference
Gender-specific associations between metabolic syndrome components and electrocardiographic abnormalities: evidence from the Birjand University of Medical Sciences Employee Health Study (BUMS EHCS)
10.1038/s41598-026-62213-y · ExternalCitation · doi-reference
Sex differences in the progression of cardiovascular-kidney-metabolic syndrome
10.1093/ehjopen/oeaf162 · ExternalCitation · doi-reference
Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome
10.1093/eurjpc/zwaf708 · ExternalCitation · doi-reference
Validation of the A&D BP UA-651 device for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010
10.1097/mbp.0000000000000020 · ExternalCitation · doi-reference
Validation of the A&D BP UA-651 device with a wide-range cuff for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010
10.1097/mbp.0000000000000100 · ExternalCitation · doi-reference
Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography
10.1111/jch.13991 · ExternalCitation · doi-reference
Validation of the A&D UA-651 Plus/UA-651SL Plus automated sphygmomanometer according to the ISO 81060-2, 2018 and ISO 81060-2 Amendment 1, 2020, which resulted in the currently pending Amendment to Amendment 1
10.1111/jch.14464 · ExternalCitation · doi-reference
Comparison of the efficiency between electrocardiogram and echocardiogram for left ventricular hypertrophy evaluation in patients with hypertension: insight from the Korean Hypertension Cohort Study
10.1111/jch.14583 · ExternalCitation · doi-reference
Left ventricular hypertrophy in hypertension: is the electrocardiogram enough for risk stratification?
10.1111/jch.14614 · ExternalCitation · doi-reference
The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: a cross-sectional study
10.1111/jch.14867 · ExternalCitation · doi-reference
Prevalence and clustering of cardiovascular risk factors: a cross-sectional survey among Nanjing adults in China
10.1136/bmjopen-2017-020530 · ExternalCitation · doi-reference
Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management
10.1152/ajpcell.00499.2025 · ExternalCitation · doi-reference
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
10.1161/cir.0000000000001184 · ExternalCitation · doi-reference
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA)
10.1161/circulationaha.104.515072 · ExternalCitation · doi-reference
Ethnic disparities in prevalence and clustering of cardiovascular disease risk factors in rural Southwest China
10.1186/s12872-019-1185-1 · ExternalCitation · doi-reference
QT interval prolongation and mortality in sepsis: a retrospective cohort study from the MIMIC-IV database
10.1186/s12872-026-05519-z · ExternalCitation · doi-reference
Predictive value of QT interval correction formulas for all-cause mortality in patients with left bundle branch block
10.1186/s12872-026-05661-8 · ExternalCitation · doi-reference
Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
10.1186/s12933-025-02735-3 · ExternalCitation · doi-reference
Cumulative incidence of mortality associated with cardiovascular-kidney-metabolic (CKM) syndrome
10.1681/asn.0000000637 · ExternalCitation · doi-reference
Prevalence of cardiovascular-kidney-metabolic syndrome in areas of Southern China where ethnic minority populations reside: a cross-sectional study
10.3389/fendo.2026.1818782 · ExternalCitation · doi-reference
Rural, urban and suburban differences in the prevalence of metabolic syndrome in individuals aged ≥ 50 years in Northwest China
10.3389/fpubh.2025.1589196 · ExternalCitation · doi-reference
Prevalence, component patterns, and lifestyle correlates of metabolic syndrome among civil servants undergoing routine health examinations in Guangzhou, China: a cross-sectional study
10.3389/fpubh.2026.1893244 · ExternalCitation · doi-reference